Sarcoma  >>  Tepezza (teprotumumab-trbw)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tepezza (teprotumumab-trbw) / Roche, Amgen
NCT00642941 / 2007-003940-30: A Study of R1507 in Participants With Recurrent or Refractory Sarcoma

Checkmark P2 data
Oct 2011 - Oct 2011: P2 data
Terminated
2
317
Europe, Canada, US, RoW
RG1507
Hoffmann-La Roche, Sarcoma Alliance for Research through Collaboration
Sarcoma
02/14
02/14

Download Options